Citation Impact
Citing Papers
Synovitis in osteoarthritis: current understanding with therapeutic implications
2017 Standout
Disulfonimide‐Catalyzed Asymmetric Reduction of N‐Alkyl Imines
2015 StandoutNobel
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
2002
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
Management of acute organophosphorus pesticide poisoning
2007 Standout
Sjögren's syndrome
2005 Standout
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
1998
Rivastigmine
1998
Schizophrenia
2009 Standout
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects
1998
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
SynCAM 1 Adhesion Dynamically Regulates Synapse Number and Impacts Plasticity and Learning
2010 StandoutNobel
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Information coding in the olfactory system: Evidence for a stereotyped and highly organized epitope map in the olfactory bulb
1994 StandoutNobel
Parkinson's disease
2009 Standout
Are delayed‐start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
2008
Mechanisms of Postnatal Neurobiological Development: Implications for Human Development
2001
Lessons from 60 years of pharmaceutical innovation
2009 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Implications of the SNARE hypothesis for intracellular membrane topology and dynamics
1994 StandoutNobel
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules
1989
Odorant Receptors Govern the Formation of a Precise Topographic Map
1998 StandoutNobel
Dendritic Anomalies in Disorders Associated with Mental Retardation
2000 Standout
Formation of Topographic Maps
1988
Alzheimer's disease
2006 Standout
Measurement of neuronal surface area using high-voltage electron microscope tomography
1992 StandoutNobel
Autism
2013 Standout
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
2009
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Alzheimer's Disease
2010 Standout
Neuronal Calcium Signaling
1998 Standout
Calumenin, a Ca2+-binding Protein Retained in the Endoplasmic Reticulum with a Novel Carboxyl-terminal Sequence, HDEF
1997 StandoutNobel
Dynamic behavior of endoplasmic reticulum in living cells
1988
Alzheimer's Disease
2004 Standout
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly
2005
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Osteoarthritis
2019 Standout
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 Standout
Cholinesterase Inhibitors for Alzheimer??s Disease
2001
Developmental potential in the first 5 years for children in developing countries
2007 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
The synaptic vesicle cycle: a cascade of protein–protein interactions
1995 StandoutNatureNobel
Emerging drugs for the treatment of knee osteoarthritis
2015
Topography in the Drosophila visual system
1993
The origin of extracellular fields and currents — EEG, ECoG, LFP and spikes
2012 Standout
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Anatomy and physiology of experimentally produced striped tecta
1981
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Treatment of the Neuropsychiatric Symptoms in Alzheimer's Disease
2003
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Alzheimer's disease
1998 Standout
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Yeast Sec23p acts in the cytoplasm to promote protein transport from the endoplasmic reticulum to the Golgi complex in vivo and in vitro.
1989 StandoutNobel
Dynamin I is a Ca(2+)-sensitive phospholipid-binding protein with very high affinity for protein kinase C.
1994 StandoutNobel
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Differential expression and regulation of multiple dynamins.
1994 StandoutNobel
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility
1985 Standout
Dendritic spines of rat cerebellar Purkinje cells: serial electron microscopy with reference to their biophysical characteristics
1988
Mouse VAP33 is associated with the endoplasmic reticulum and microtubules
2000 StandoutNobel
Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer’s disease
2000
Proton Magnetic Resonance Spectroscopy as a Probe into the Pathophysiology ofA utismS pectrumD isorders (ASD ): A Review
2013
Physical Activity and Public Health in Older Adults
2007 Standout
Current and Novel Approaches to the Drug Treatment of Schizophrenia
2001
Emerging drugs for schizophrenia
2008
An analogue approach to the travelling salesman problem using an elastic net method
1987 StandoutNature
Environmental Determinants of Quality of Life in Nursing Home Residents with Severe Dementia
2012
Muscarinic Receptor Agonists and Antagonists
2001
Muscarinic Receptor Agonists in Alzheimer??s Disease
1999
Gliding movement of and bidirectional transport along single native microtubules from squid axoplasm: evidence for an active role of microtubules in cytoplasmic transport.
1985
A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer’s disease
1999
The selective muscarinic M1 agonist AF102B decreases levels of total A? in cerebrospinal fluid of patients with Alzheimer's disease
2000
Neuronal Substrates of Sleep and Epilepsy
2001
Constitutive overexpression of the Drosophila period protein inhibits period mRNA cycling.
1994 StandoutNobel
Nuclear congression and membrane fusion: two distinct events in the yeast karyogamy pathway.
1994 StandoutNobel
Works of N. Bodick being referenced
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1997
Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
1997
Effects of Central Muscarinic-1 Receptor Stimulation on Blood Pressure Regulation
1997
Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease
1997
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.
1997
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
1997
Microtubule disarray in cortical dendrites and neurobehavioral failure. I. Golgi and electron microscopic studies
1982
Serial reconstruction of microtubular arrays within dendrites of the cat retinal ganglion cell: The cytoskeleton of a vertebrate dendrite
1983
Microtubular disarray in cortical dendrites and neurobehavioral failure. II. Computer reconstruction of perturbed microtubular arrays
1982
A more rational approach to new-product development.
2008
Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
1997
Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain
2018
Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study
2016
Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease
1997
Safety and efficacy of FX006 in patients with osteoarthritis of the knee
2014
Growing optic nerve fibers follow neighbors during embryogenesis.
1980
Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist
1997
Measuring behavior, mood, and psychiatric symptoms in Alzheimer disease.
1997